Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CanSino Biologics
China approves clinical trials for Livzon Pharma unit’s COVID-19 vaccine
China’s medical products regulator has approved clinical trials for a COVID-19 vaccine candidate developed by a subsidiary of…
China’s CAS COVID-19 vaccine induces immune response in mid-stage tests
A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune…
Sinovac’s COVID-19 vaccine candidate get emergency use approval in China
China has also approved the use of CanSino Biologics’ vaccine candidate
CanSino gets COVID-19 vaccine patent from China’s IP regulator
As per reports by state media the patent was issued on August 11
CanSino to commence Phase III COVID-19 vaccine trial in Saudi Arabia
The vaccine uses adenovirus type-5 (Ad5) to carry genetic material from the coronavirus into the body
China’s CanSino in talks for COVID vaccine Phase III trial overseas
Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests
Sartorius supports the development of the first vaccine candidate against the novel coronavirus to…
Sartorius’ BIOSTAT STR50 bioreactor system was previously used during CanSinoBIO’s and the Institute of Bioengineering’s joint…